These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9027138)
1. [Comparison of the efficacy of various strains of mumps vaccine: a school survey]. Toscani L; Batou M; Bouvier P; Schlaepfer A Soz Praventivmed; 1996; 41(6):341-7. PubMed ID: 9027138 [TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. Ong G; Goh KT; Ma S; Chew SK J Infect; 2005 Nov; 51(4):294-8. PubMed ID: 16291282 [TBL] [Abstract][Full Text] [Related]
3. [Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)]. Chamot E; Toscani L; Egger P; Germann D; Bourquin C Rev Epidemiol Sante Publique; 1998 Mar; 46(2):100-7. PubMed ID: 9592852 [TBL] [Abstract][Full Text] [Related]
4. [Mumps epidemic in vaccinated children in West Switzerland]. Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835 [TBL] [Abstract][Full Text] [Related]
5. [Mumps epidemiology in Switzerland: results from the Sentinella surveillance system 1986-1993. Sentinella Work Group]. Zimmermann H; Matter HC; Kiener T Soz Praventivmed; 1995; 40(2):80-92. PubMed ID: 7747525 [TBL] [Abstract][Full Text] [Related]
6. Impact of the MMR vaccine on the incidence of mumps in the Community of Madrid and evaluation of the effectiveness of the Jeryl-Lynn strain. Years 1998-2016. Latasa P; Ordobás M; Garrido-Estepa M; Sanz JC; Gil de Miguel A; García-Comas L Med Clin (Barc); 2019 Oct; 153(7):276-280. PubMed ID: 30857795 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 2000: a case-cohort study. Richard JL; Zwahlen M; Feuz M; Matter HC; Eur J Epidemiol; 2003; 18(6):569-77. PubMed ID: 12908724 [TBL] [Abstract][Full Text] [Related]
8. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases. Vaccine; 1998 May; 16(8):818-22. PubMed ID: 9627939 [TBL] [Abstract][Full Text] [Related]
9. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869 [TBL] [Abstract][Full Text] [Related]
10. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children. Feiterna-Sperling C; Brönnimann R; Tischer A; Stettler P; Durrer P; Gaedicke G Pediatr Infect Dis J; 2005 Dec; 24(12):1083-8. PubMed ID: 16371870 [TBL] [Abstract][Full Text] [Related]
11. An outbreak of mumps in a population partially vaccinated with the Rubini strain. Germann D; Ströhle A; Eggenberger K; Steiner CA; Matter L Scand J Infect Dis; 1996; 28(3):235-8. PubMed ID: 8863352 [TBL] [Abstract][Full Text] [Related]
12. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369 [TBL] [Abstract][Full Text] [Related]
13. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
14. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Tischer A; Gerike E Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536 [TBL] [Abstract][Full Text] [Related]
15. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
16. Mumps outbreak in vaccinated children in Gipuzkoa (Basque Country), Spain. Montes M; Cilla G; Artieda J; Vicente D; Basterretxea M Epidemiol Infect; 2002 Dec; 129(3):551-6. PubMed ID: 12558338 [TBL] [Abstract][Full Text] [Related]
17. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells. Glück R; Hoskins JM; Wegmann A; Just M; Germanier R Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774 [TBL] [Abstract][Full Text] [Related]
18. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Dayan GH; Rubin S Clin Infect Dis; 2008 Dec; 47(11):1458-67. PubMed ID: 18959494 [TBL] [Abstract][Full Text] [Related]
19. [A look back at 2 mumps outbreaks]. Paccaud MF; Hazeghi P; Bourquin M; Maurer AM; Steiner CA; Seiler AJ; Helbling P; Zimmermann H Soz Praventivmed; 1995; 40(2):72-9. PubMed ID: 7747524 [TBL] [Abstract][Full Text] [Related]
20. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project. Black S; Shinefield H; Ray P; Lewis E; Chen R; Glasser J; Hadler S; Hardy J; Rhodes P; Swint E; Davis R; Thompson R; Mullooly J; Marcy M; Vadheim C; Ward J; Rastogi S; Wise R Pediatr Infect Dis J; 1997 May; 16(5):500-3. PubMed ID: 9154545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]